Abstract
Novel bottromycin derivatives were synthesized from bottromycin A(2) via a hydrazide derivative as a common intermediate. Seventeen derivatives were subjected to in vitro evaluation against drug-resistant gram-positive bacteria. Some compounds showed potent anti-MRSA and anti-VRE activity, as did bottromycin A(2). Notably, a propyl ketone derivative exhibited good antibacterial activity with excellent metabolite stability.
Copyright © 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / chemistry*
-
Anti-Bacterial Agents / metabolism
-
Anti-Bacterial Agents / pharmacology*
-
Drug Resistance, Bacterial
-
Enterococcaceae / drug effects
-
Gram-Positive Bacteria / drug effects*
-
Gram-Positive Bacterial Infections / drug therapy
-
Humans
-
Methicillin-Resistant Staphylococcus aureus / drug effects*
-
Mice
-
Microbial Sensitivity Tests
-
Peptides, Cyclic / chemical synthesis
-
Peptides, Cyclic / chemistry
-
Peptides, Cyclic / metabolism
-
Peptides, Cyclic / pharmacology
-
Plasma / metabolism
-
Vancomycin / pharmacology
Substances
-
Anti-Bacterial Agents
-
Peptides, Cyclic
-
bottromycin A(2)
-
Vancomycin